scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1027317665 |
P356 | DOI | 10.1007/S13277-015-4243-Z |
P698 | PubMed publication ID | 26490991 |
P2093 | author name string | Shun-Fa Yang | |
Tzu-Ming Chang | |||
Chew-Teng Kor | |||
Chung-Bao Hsieh | |||
Tsung-Ming Chen | |||
Ting-Ying Lee | |||
Kuan-Chun Hsueh | |||
P2860 | cites work | Early respiratory complications after liver transplantation | Q26823081 |
Management of hepatocellular carcinoma: An update | Q27860530 | ||
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | Q30479629 | ||
Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation | Q33508431 | ||
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study | Q33937741 | ||
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma | Q33947429 | ||
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience | Q34630506 | ||
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? | Q35586420 | ||
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome | Q35648684 | ||
Donor safety in live-related liver transplantation | Q35675126 | ||
Resection and liver transplantation for hepatocellular carcinoma. | Q36140302 | ||
Biliary complications after a right-lobe living donor liver transplantation | Q36279884 | ||
Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection? | Q36653262 | ||
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators | Q37087879 | ||
Surgical treatment of hepatocellular carcinoma: expert consensus statement | Q37768894 | ||
Long-term results of liver transplantation | Q37863928 | ||
Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis | Q38029966 | ||
Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis | Q38030887 | ||
Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis | Q38033646 | ||
Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria | Q38048224 | ||
Assessment of causes of early death after twenty years of liver transplantation | Q38102311 | ||
Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. | Q38135695 | ||
Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma | Q38216005 | ||
Living donor liver transplantation for patients with hepatocellular carcinoma | Q38221511 | ||
Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma | Q38492092 | ||
Recurrence of hepatocellular carcinoma after liver transplantation: an update | Q38594469 | ||
Primary liver transplantation vs liver resection followed by transplantation for transplantable hepatocellular carcinoma: Liver functional quality and tumor characteristics matter | Q41851468 | ||
Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection | Q43038132 | ||
Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. | Q43562799 | ||
Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma | Q43693428 | ||
Outcomes with split liver transplantation are equivalent to those with whole organ transplantation | Q43835446 | ||
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? | Q43907269 | ||
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence | Q44619453 | ||
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis | Q44713104 | ||
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival | Q45080893 | ||
Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma | Q45242116 | ||
High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study | Q45357441 | ||
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. | Q45958504 | ||
Excellent outcome in 238 consecutive living donor liver transplantations using the right liver graft in a large volume single center. | Q45958856 | ||
Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma. | Q46046878 | ||
Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma | Q46125100 | ||
Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation | Q46797280 | ||
Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant | Q46798605 | ||
ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor. | Q47825124 | ||
Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. | Q50777303 | ||
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. | Q51539743 | ||
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. | Q51541140 | ||
Section 11. Radiological intervention approaches to biliary complications after living donor liver transplantation. | Q53545244 | ||
Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation | Q57763656 | ||
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation | Q58860138 | ||
Small hepatocellular carcinoma in Child A cirrhotic patients: Hepatic resection versus transplantation | Q73379312 | ||
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation | Q80820533 | ||
Liver transplantation for hepatocellular carcinoma | Q81502353 | ||
Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications | Q82350262 | ||
Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? | Q82845317 | ||
Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis | Q83440082 | ||
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria | Q83508509 | ||
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma | Q84560169 | ||
Hepatocellular carcinoma--resection or transplant? | Q84958635 | ||
Why does living donor liver transplantation flourish in Asia? | Q86484708 | ||
Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion | Q87006181 | ||
Biliary complications adversely affect patient and graft survival after liver retransplantation | Q87031383 | ||
National assessment of early biliary complications following liver transplantation: incidence and outcomes | Q87195504 | ||
Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection | Q87317868 | ||
P433 | issue | 3 | |
P304 | page(s) | 4193-4201 | |
P577 | publication date | 2015-10-22 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | The role of liver transplantation or resection for patients with early hepatocellular carcinoma | |
P478 | volume | 37 |
Q103007648 | Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma |
Q92462179 | Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib |
Q38758158 | Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection |
Q90705583 | Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line |
Q37399648 | Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries |
Q89747123 | MELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study |
Q90781328 | MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4) |
Q42287550 | Resection or Transplant in Early Hepatocellular Carcinoma |